Insulet to sell $65 million of senior notes

Insulet Corp., which makes an insulin infusion system for diabetics, said Tuesday it is selling $65 million worth of convertible senior notes due 2013 to qualified institutional buyers.

The company said it also will grant initial buyers the option to purchase up to an added $10 million worth of notes to cover over-allotments, if any.

The notes will be convertible under certain circumstances into cash and stock. The interest rate, conversion rate and other terms will be negotiated.

Insulet said it will use proceeds from the offering to repay and terminate its outstanding term loan and for general corporate purposes.

Comment (0)
Recommended (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 661360, ~/articles/articlehandler.aspx, 8/30/2008 10:38:32 AM,

Sign up for FREE Motley Fool site access!

Already registered? Login Here

It’s FREE! Enter your email address, and we’ll rush you to the article you're looking for right now.

Privacy / Legal Information

We will use your email address only to keep you informed about updates to our web site and about other products and services that we think might interest you. The Motley Fool respects your privacy. Please read our Privacy Statement

.

Related Tickers

Insulet Corp

PODD Up! $14.34 +0.08 (+0.56%) 4:00 PM
CAPS Rating:
31 Outperforms
12 Underperforms
Rate This Stock

Major Indices

S&P 5001,282.83 -1.37%
DJIA11,543.55 -1.47%
RSL 2K739.50 -1.11%
NASD2,367.52 -1.83%
Updated: 5:10:01 PM
Sponsored by:

The Motley Poll

Where will the U.S. dollar go from here?

Sponsored by: